This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DEH vs. CDRE, ESTA, AVNS, SMTI, AVR, INGN, LAKE, ZJYL, MLSS, and NTRBShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Cadre (CDRE), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Milestone Scientific (MLSS), and Nutriband (NTRB). D8 vs. Cadre Establishment Labs Avanos Medical Sanara MedTech Anteris Technologies Global Inogen Lakeland Industries Jin Medical International Milestone Scientific Nutriband D8 (NYSE:DEH) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability. Is DEH or CDRE more profitable? Cadre has a net margin of 6.34% compared to D8's net margin of 0.00%. Cadre's return on equity of 12.88% beat D8's return on equity.Company Net Margins Return on Equity Return on Assets D8N/A N/A N/A Cadre 6.34%12.88%6.06% Does the media prefer DEH or CDRE? In the previous week, Cadre had 3 more articles in the media than D8. MarketBeat recorded 3 mentions for Cadre and 0 mentions for D8. Cadre's average media sentiment score of 0.92 beat D8's score of -0.73 indicating that Cadre is being referred to more favorably in the news media. Company Overall Sentiment D8 Negative Cadre Positive Do analysts rate DEH or CDRE? Cadre has a consensus target price of $37.00, indicating a potential upside of 24.75%. Given Cadre's stronger consensus rating and higher possible upside, analysts plainly believe Cadre is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cadre 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in DEH or CDRE? Cadre received 16 more outperform votes than D8 when rated by MarketBeat users. CompanyUnderperformOutperformD8N/AN/ACadreOutperform Votes1655.17% Underperform Votes1344.83% Which has stronger earnings & valuation, DEH or CDRE? Cadre has higher revenue and earnings than D8. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioD8N/AN/A-$9.46MN/AN/ACadre$567.56M2.12$38.64M$0.9032.96 Do institutionals & insiders hold more shares of DEH or CDRE? 65.4% of D8 shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 37.0% of Cadre shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryCadre beats D8 on 12 of the 13 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$356.64M$9.32B$5.56B$19.21BDividend YieldN/A1.63%5.36%4.01%P/E RatioN/A19.3322.8133.50Price / SalesN/A70.62406.3529.16Price / CashN/A19.6738.1817.52Price / Book68.925.186.794.55Net Income-$9.46M$284.66M$3.23B$1.02B D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$8.27+4.0%N/A+2,564.3%$356.64MN/A0.003CDRECadre3.063 of 5 stars$29.31flat$37.00+26.2%-13.2%$1.19B$567.56M35.312,240Upcoming EarningsEx-DividendESTAEstablishment Labs2.7777 of 5 stars$30.26+2.3%$57.40+89.7%-36.8%$872.88M$166.03M-11.73960Upcoming EarningsAVNSAvanos Medical2.1613 of 5 stars$12.74+0.3%N/A-37.6%$586.26M$687.80M37.484,040Upcoming EarningsShort Interest ↑SMTISanara MedTech2.1746 of 5 stars$32.14+1.6%$48.50+50.9%+1.4%$285.66M$86.67M-32.4660Positive NewsAVRAnteris Technologies GlobalN/A$5.51+2.2%$16.50+199.5%N/A$198.49M$2.71M0.00138Positive NewsINGNInogen2.2326 of 5 stars$7.28+0.1%$7.00-3.8%+0.7%$195.74M$335.71M-3.241,030Upcoming EarningsPositive NewsLAKELakeland Industries4.7657 of 5 stars$16.74+0.9%$27.00+61.3%-5.4%$159.01M$167.21M-186.001,800ZJYLJin Medical InternationalN/A$0.89+3.2%N/A-79.0%$140.08M$23.50M0.00245MLSSMilestone Scientific0.8901 of 5 stars$0.97-0.7%$1.25+29.5%+67.7%$75.64M$8.63M-13.7830Analyst ForecastNews CoverageGap DownNTRBNutriband2.8131 of 5 stars$5.68-2.7%$13.00+128.9%+82.5%$63.08M$2.02M-8.0010Earnings ReportGap Up Related Companies and Tools Related Companies CDRE Competitors ESTA Competitors AVNS Competitors SMTI Competitors AVR Competitors INGN Competitors LAKE Competitors ZJYL Competitors MLSS Competitors NTRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DEH) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
